Terms: = Uterine cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Diagnosis
805 results:
1. Communicable and Non-communicable Diseases diagnosis and Treatment Service Availability at Primary Health Care Units During COVID-19 Outbreak in Ethiopia.
Gonete TZ; Asseffa NA; Gashu KD; Tilahun B; Angaw DA; Jisso M; Tamiso A; Alemayehu A; Fikre R; Abdisa B; Sime H; Yesuf EA; Umer A; Kebede M; Mohammed H; Yazie B; Gurmu KK; Endehabtu BF
Ethiop J Health Sci; 2023 Oct; 33(Spec Iss 2):95-104. PubMed ID: 38352666
[TBL] [Abstract] [Full Text] [Related]
2. Characteristic hysteroscopy appearance considerations for detecting uterine endometrial malignancies.
Matsumoto Y; Yamaguchi K; Maruyama M; Sone K; Mori-Uchino M; Hirota Y; Wada-Hiraike O; Osuga Y
J Obstet Gynaecol Res; 2024 Apr; 50(4):566-571. PubMed ID: 38214188
[TBL] [Abstract] [Full Text] [Related]
3. Differentiating uterine Sarcoma From Atypical Leiomyoma on Preoperative Magnetic Resonance Imaging Using Logistic Regression Classifier: Added Value of Diffusion-Weighted Imaging-Based Quantitative Parameters.
Kim H; Rha SE; Shin YR; Kim EH; Park SY; Lee SL; Lee A; Kim MR
Korean J Radiol; 2024 Jan; 25(1):43-54. PubMed ID: 38184768
[TBL] [Abstract] [Full Text] [Related]
4. Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer.
Zhong W; Liu Y; Zhang L; Zhuang W; Chen J; Huang Z; Zheng Y; Huang Y
PeerJ; 2023; 11():e16424. PubMed ID: 38077439
[TBL] [Abstract] [Full Text] [Related]
5. Diagnostic and pre-treatment intervals among patients with cervical cancer attending care at the Uganda cancer Institute: a cross-sectional study.
Lacika JL; Wabinga H; Kagaayi J; Opito R; Orach CG; Mwaka AD
BMC Womens Health; 2023 Nov; 23(1):633. PubMed ID: 38012615
[TBL] [Abstract] [Full Text] [Related]
6. Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic implications and pitfalls.
Moura MS; Costa J; Velasco V; Kommoss F; Oliva E; Le Loarer F; McCluggage WG; Razack R; Treilleux I; Mills A; Longacre T; Devouassoux-Shisheboran M; Hostein I; Azmani R; Blanchard L; Hartog C; Soubeyran I; Khalifa E; Croce S
Histopathology; 2024 Feb; 84(3):451-462. PubMed ID: 37988282
[TBL] [Abstract] [Full Text] [Related]
7. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
[TBL] [Abstract] [Full Text] [Related]
8. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
Schuurman TN; Schaafsma M; To KH; Verhoef VMJ; Sikorska K; Siebers AG; Wenzel HHB; Bleeker MCG; Roes EM; Zweemer RP; de Vos van Steenwijk PJ; Yigit R; Beltman JJ; Zusterzeel PLM; Lok CAR; Bekkers RLM; Mom CH; van Trommel NE
Lancet Oncol; 2023 Dec; 24(12):1349-1358. PubMed ID: 37952541
[TBL] [Abstract] [Full Text] [Related]
9. Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
Luckett R; Ramogola-Masire D; Gompers A; Moraka N; Moyo S; Sedabadi L; Tawe L; Kashamba T; Gaborone K; Mathoma A; Noubary F; Kula M; Grover S; Dreyer G; Botha MH; Makhema J; Shapiro R; Hacker MR
Int J Gynaecol Obstet; 2024 May; 165(2):507-518. PubMed ID: 37950533
[TBL] [Abstract] [Full Text] [Related]
10. Cervical pre-cancer screening by visual inspection of the cervix after application of acetic acid in rural Burkina Faso: evaluation of women's knowledge, screening practice habits, acceptability and prevalence of risk factors and lesions in Boussé health district.
Tassembedo S; Winter CH; Traore IT; Ouattara A; Sawadogo M; Meda N
Pan Afr Med J; 2023; 45():135. PubMed ID: 37790161
[TBL] [Abstract] [Full Text] [Related]
11. Diagnostic Accuracy of Ultrasound in the diagnosis of uterine Leiomyomas and Sarcomas.
Raffone A; Raimondo D; Neola D; Travaglino A; Raspollini A; Giorgi M; Santoro A; De Meis L; Zannoni GF; Seracchioli R; Casadio P; Guida M
J Minim Invasive Gynecol; 2024 Jan; 31(1):28-36.e1. PubMed ID: 37778636
[TBL] [Abstract] [Full Text] [Related]
12. Survival of women with cervical cancer in East Africa: a systematic review and meta-analysis.
Kassa R; Irene Y; Woldetsadik E; Kidane E; Higgins M; Dejene T; Wells J
J Obstet Gynaecol; 2023 Dec; 43(2):2253308. PubMed ID: 37776893
[TBL] [Abstract] [Full Text] [Related]
13. A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.
Inturrisi F; de Sanjosé S; Desai KT; Dagnall C; Egemen D; Befano B; Rodriguez AC; Jeronimo JA; Zuna RE; Hoffman A; Farhat Nozzari S; Walker JL; Perkins RB; Wentzensen N; Palefsky JM; Schiffman M
Int J Cancer; 2024 Jan; 154(2):241-250. PubMed ID: 37772799
[TBL] [Abstract] [Full Text] [Related]
14. Awareness, Knowledge and Attitude Regarding Cervical cancer among Women Living with HIV in the Souss-Massa Region, Southern Morocco: A Cross-Sectional Study.
Arechkik A; Lahlou L; Kharbach A; Baba MA; Obtel M; Razine R
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2875-2884. PubMed ID: 37642077
[TBL] [Abstract] [Full Text] [Related]
15. Is endometrial sampler SAP-1 a good way to diagnose the common intrauterine occupying lesions?-A diagnostic study.
Hong Y
Niger J Clin Pract; 2023 Jul; 26(7):896-901. PubMed ID: 37635572
[TBL] [Abstract] [Full Text] [Related]
16. Timing of Colposcopy and Risk of Cervical cancer.
Alimena S; Lykken JM; Tiro JA; Chubak J; Kamineni A; Haas JS; Werner C; Kobrin SC; Feldman S
Obstet Gynecol; 2023 Nov; 142(5):1125-1134. PubMed ID: 37607530
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic value of serum human epididymis protein 4, carbohydrate antigen 125 and their combination in endometrial cancer: A meta-analysis.
Wu Q; Bai SN; Song LY; Wu WF; Han LN
Medicine (Baltimore); 2023 Aug; 102(33):e34737. PubMed ID: 37603503
[TBL] [Abstract] [Full Text] [Related]
18. Triage Value of Cervical Exfoliated Cell DNA Ploidy Analysis in Cervical High-Risk Human Papillomavirus-Positive Women.
Chu B; Dong J; Chen Y; Ru X; Zhang W; Chen Y; Zhang X; Cheng X
J Low Genit Tract Dis; 2023 Oct; 27(4):331-336. PubMed ID: 37589311
[TBL] [Abstract] [Full Text] [Related]
19. Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.
Huvila J; Thompson EF; Vanden Broek J; Lum A; Senz J; Leung S; Gilks CB; Köbel M; McAlpine JN; Jamieson A
Histopathology; 2023 Dec; 83(6):880-890. PubMed ID: 37580913
[TBL] [Abstract] [Full Text] [Related]
20. [The value of T2 mapping for evaluating the pathological type, grade and depth of myometrial invasion in endometrial carcinoma].
Li SJ; Zhang ZX; Liu J; Wang WJ; Wang J; Zhang Y; Cheng JL
Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):673-680. PubMed ID: 37580272
[No Abstract] [Full Text] [Related]
[Next]
